Stock ScreenerStock IdeasZen Ratings + Top Analysts
Stocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Feb 27, 2026
The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.

Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
LTM
LATAM AIRLINES GROUP SA
NYSE
Airlines
A$35.28B$58.370.62%$1.88B18.06x20.11
Chile
32
JLL
JONES LANG LASALLE INC
NYSE
Real Estate Services
A$14.83B$316.591.81%$1.34B18.92x1.36
United States
38
BCO
BRINKS CO
NYSE
Security & Protection Services
A$5.38B$129.580.29%$806.70M32.48x24.42
United States
46
INDV
INDIVIOR PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
A$4.20B$33.631.72%$316.00M25.67x-7.84
United Kingdom
39
VISN
VISTANCE NETWORKS INC
NASDAQ
Communication Equipment
A$3.94B$17.80-0.84%$1.70B4.34x-3.84
United States
24
CALX
CALIX INC
NYSE
Software - Application
A$3.35B$51.07-4.47%$38.44M189.15x0.23
United States
39
QTWO
Q2 HOLDINGS INC
NYSE
Software - Application
A$2.95B$47.20-0.21%$113.56M56.19x0.93
United States
36
DBD
DIEBOLD NIXDORF INC
NYSE
Software - Application
A$2.91B$82.672.44%$331.90M32.17x2.50
United States
42
VCYT
VERACYTE INC
NASDAQ
Biotechnology
A$2.82B$35.720.08%$57.00M91.59x0.09
United States
45
HCI
HCI GROUP INC
NYSE
Insurance - Property & Casualty
A$2.12B$163.504.41%$301.16M9.47x1.82
United States
50
EXTR
EXTREME NETWORKS INC
NASDAQ
Communication Equipment
A$1.88B$14.001.89%$66.35M200.00x11.19
United States
34
INVA
INNOVIVA INC
NASDAQ
Biotechnology
A$1.81B$24.243.50%$214.76M12.83x0.42
United States
45
ATRC
ATRICURE INC
NASDAQ
Medical Instruments & Supplies
A$1.55B$31.190.16%$16.25M-129.96x0.33
United States
40
FIVN
FIVE9 INC
NASDAQ
Software - Infrastructure
A$1.37B$17.850.11%$141.06M35.00x1.28
United States
58
DFIN
DONNELLEY FINANCIAL SOLUTIONS INC
NYSE
Capital Markets
A$1.27B$49.581.16%$122.10M42.02x1.11
United States
34
UVE
UNIVERSAL INSURANCE HOLDINGS INC
NYSE
Insurance - Property & Casualty
A$917.20M$32.702.48%$174.52M7.47x5.24
United States
40
TBLA
TABOOLACOM LTD
NASDAQ
Internet Content & Information
A$818.92M$2.95-6.05%$120.94M21.07x0.78
United States
53
MNTN
MNTN INC
NYSE
Software - Application
A$712.87M$9.650.42%-$9.62M-74.23x0.24
United States
26
NRDS
NERDWALLET INC
NASDAQ
Internet Content & Information
A$689.23M$10.327.95%$115.20M15.64x0.23
United States
71
BWMX
BETTERWARE DE MEXICO SAPI DE CV
NYSE
Specialty Retail
A$682.89M$18.30-2.03%$145.14MN/A6.80
Mexico
24
TCMD
TACTILE SYSTEMS TECHNOLOGY INC
NASDAQ
Medical Devices
A$664.42M$29.613.35%$39.02M35.67x0.25
United States
54
EVER
EVERQUOTE INC
NASDAQ
Internet Content & Information
A$585.72M$16.295.10%$59.50M10.93x0.46
United States
67
BWMN
BOWMAN CONSULTING GROUP LTD
NASDAQ
Engineering & Construction
A$574.18M$33.051.94%$38.00M33.72x0.95
United States
54
ORGO
ORGANOGENESIS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
A$521.61M$4.111.99%$18.04M-34.25x0.49
United States
20
LE
LANDS' END INC
NASDAQ
Apparel Retail
A$491.87M$16.10-0.31%$86.84M43.51x2.69
United States
35
QUAD
QUAD/GRAPHICS INC
NYSE
Specialty Business Services
A$379.43M$7.26-1.36%$161.60M12.74x8.74
United States
38
EGHT
8X8 INC
NASDAQ
Software - Application
A$309.29M$2.224.23%$49.76M-111.00x3.63
United States
12
FENC
FENNEC PHARMACEUTICALS INC
NASDAQ
Biotechnology
A$249.40M$8.87-0.45%-$4.53M-35.48x-11.97
United States
30
LTRX
LANTRONIX INC
NASDAQ
Communication Equipment
A$241.72M$6.091.67%-$4.74M-26.48x0.64
United States
17
ELMD
ELECTROMED INC
NYSEMKT
Medical Devices
A$197.95M$23.923.33%$13.13M22.36x0.21
United States
54
INFU
INFUSYSTEM HOLDINGS INC
NYSEMKT
Medical Instruments & Supplies
A$174.08M$8.56-0.47%$24.16M32.92x0.78
United States
45

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have access to Premium? Sign In
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.